| 000 | 01733 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516132624.0 | ||
| 264 | 0 | _c20130906 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1872-7077 | ||
| 024 | 7 |
_a10.1016/j.etap.2012.12.008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalama, Mohamed | |
| 245 | 0 | 0 |
_aRole of L-thyroxin in counteracting rotenone induced neurotoxicity in rats. _h[electronic resource] |
| 260 |
_bEnvironmental toxicology and pharmacology _cMar 2013 |
||
| 300 |
_a270-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCatalepsy _xchemically induced |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDopaminergic Neurons _xdrug effects |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xdrug therapy |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aRotenone _xtoxicity |
| 650 | 0 | 4 |
_aSubstantia Nigra _xdrug effects |
| 650 | 0 | 4 |
_aThyroxine _xpharmacology |
| 650 | 0 | 4 |
_aTremor _xchemically induced |
| 650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
| 700 | 1 | _aHelmy, Basem | |
| 700 | 1 | _aEl-Gamal, Mohamed | |
| 700 | 1 | _aReda, Amr | |
| 700 | 1 | _aEllaithy, Amr | |
| 700 | 1 | _aTantawy, Dina | |
| 700 | 1 | _aMohamed, Mie | |
| 700 | 1 | _aEl-Gamal, Aya | |
| 700 | 1 | _aSheashaa, Hussein | |
| 700 | 1 | _aSobh, Mohamed | |
| 773 | 0 |
_tEnvironmental toxicology and pharmacology _gvol. 35 _gno. 2 _gp. 270-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.etap.2012.12.008 _zAvailable from publisher's website |
| 999 |
_c22455146 _d22455146 |
||